(Q74424848)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13407232%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Anticholinergic drugs in peptic ulcer; their current status (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13407232%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

J B KIRSNER

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13407232%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

H FORD

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13407232%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

R S KASSRIEL

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13407232%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 March 1957

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13407232%20AND%20SRC:MED&resulttype=core&format=json

Medical Clinics of North America

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13407232%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13407232%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13407232%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

495-520

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13407232%20AND%20SRC:MED&resulttype=core&format=json

The screening of antiulcer drugs by a quantal procedure

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Anticholinesterase activity of drugs assayed by a rapid colorimetric method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Clinical appraisal of gastrointestinal antispasmodics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

A clinical comparison of the antispasmodic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Gastric antacid and anti-secretory drugs: a survey based primarily on their effects upon gastric secretion in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Current views on the physiology of the gastric secretions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Effects of Anticholinergic Drugs on Pepsin Production and Uropepsinogen Excretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Optimal effective dose of anticholinergic drug in peptic ulcer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Determination of quaternary ammonium compounds including acetylcholine, tetraethylammonium, and hexamethonium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Release of gastrin in response to bathing the pyloric mucosa with acetylcholine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Clinical assessment of drugs which inhibit gastric secretion with special reference to hexamethonium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Role of anticholinergic drugs in treatment of peptic ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Certain problems of the medical management of peptic ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Drugs affecting the autonomic nervous system. I. Clinical application in gastrointestinal disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Relative effectiveness of anticholinergic drugs on basal gastric secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

The mechanism of relief of pain in peptic ulcer by banthine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Inhibition of acid-induced peptic ulcer pain by local anesthetics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Relationship of ulcer pain to pH and motility of stomach and duodenum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Effects of suggestion and conditioning on the action of chemical agents in human subjects; the pharmacology of placebos

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Use of controls in medical research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

The onus of proving the value of remedies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Efficacy of methantheline (Banthine) bromide in therapy of the unstable colon; a long-term double blindfold controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Prolonged drug therapy in peptic ulcer: I. An evaluation of banthine as an adjunct to conventional ulcer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Prolonged anticholinergic therapy of duodenal ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Clinical evaluation of methantheline (banthine) bromide in gastroenterology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Some clinical problems in small intestinal physiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

The newer anticholinergic agents. I. Effectiveness as anhydrotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Antispasmodics: from empiricism to controlled experimentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Effects of b-diethylaminoethyl xanthene 9-carboxylate methobromide (banthine) on human gastrointestinal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Clinical trial of banthine in 100 patients with peptic ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Banthine in the therapy of peptic ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Treatment of intractable peptic ulcer with methantheline (banthine) bromide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Banthine in the treatment of peptic ulcer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Anticholinergic drugs in gastrointestinal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Pharmacological properties of a new parasympathetic blocking agent, N,N dimethyl 4-piperidylidene 1,1 diphenylmethane methyl sulfate (Prantal)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Prantal in long-term anticholinergic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

An evaluation of prantal in the management of patients with resistant chronic duodenal ulcer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Physiological economy of darstine, 5-methyl-4-phenyl-1-(piperidyl)-3-hexanol methobromide, visceral anticholinergic agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Preliminary evaluation of a new drug, antrenyl; effect on gastric secretion, motility and results in the symptomatic care of peptic ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

A new antiulcer drug; a clinical and radiological evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

A comparative study of banthine and of antrenyl in the treatment of duodenal ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Further experience with anticholinergic drugs: a clinical appraisal in 201 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Depression of gastric secretion by a new anticholinergic agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Clinical experiences with four new antispasmodic substances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

The pharmacology of 1-cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol methsulfate, compound 14045, a new parasympathetic depressant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Effects of tricyclamol on gastric secretion and gastrointestinal motility in peptic ulcer; experimental studies and clinical observations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

A study of the action of tricyclamol chloride.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Effects of a new cholinergic blocking agent (SKF-1637) on gastric motor and secretory activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Oral use of methscopolamine (pamine) bromide in treatment of duodenal ulcer; effect on human gastric secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Pro-banthine in the treatment of peptic ulcer; a clinical evaluation with gastric secretory, motility and gastroscopic studies, report of 60 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

The effect of a new parasympathetic blocking agent on gastric secretion and gastrointestinal motility in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

Clinical evaluation of a sustained release belladonna preparation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

The relationship between chemical structure and biological activity of compounds with atropine-like activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2934451-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-7125(16)34451-0

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13407232%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference